Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Recruiting · NCT03664609
Conditions: Parkinson Disease, Essential Tremor, Dystonia
At a glance
- Research payments reported, 2025
- $6,105
- U.S. investigators named
- 4
- Sites paid
- 4
- Planned or actual enrollment
- 5,000
About the trial
- Sponsor
- Boston Scientific Corporation
- Tested
- Deep Brain Stimulation (device)
- Dates
- Started 2019-03-12; completion 2028-12
- Results posted
- Not yet
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
From ClinicalTrials.gov, last updated 2026-10-07. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Boston Scientific Corporation reported $6,105 in research payments for this study in 2025 (11 payments).
Products named: Vercise
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Francisco A. Ponce, MD Neurosurgery · Phoenix, AZ
- Cong Zhi Zhao, M.D. Neurology · Fresno, CA
- Theresa Zesiewicz, MD Neurology · Tampa, FL
- Nestor D. Tomycz, MD Neurosurgery · Washington, PA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- St Josephs Hospital and Medical Center, AZ $2,250
- St Luke's Regional Medical Center, ID $1,555
- Allegheny Singer Research Institute $1,300
- University of South Florida $1,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.